
|Articles|December 1, 2002
2002: Specialists pleased with ongoing retinal progress
Therapies for retinal diseases that re-mained untreatable for decades are seeing major advances. So much so that Jason Slakter, MD, clinical professor of ophthalmology, New York University School of Medicine, and surgeon director, Manhattan Eye, Ear, & Throat Hospital, New York, has proclaimed the first years of the new mil-lennium as the "Decade of the Macula."
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies
3
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
4
Eye exams could enable earlier detection of systemic disease
5



























